Press Release: SNDL Reports First Quarter 2025 Financial and Operational Results

Dow Jones
01 May

SNDL Reports First Quarter 2025 Financial and Operational Results

Canada NewsWire

EDMONTON, AB, May 1, 2025

The Company Delivers Record Gross Margin and Positive Cash Flow; Announces Strategic Review of U.S. Platform and Listing Structure

EDMONTON, AB, May 1, 2025 /CNW/ - SNDL Inc. $(SNDL)$ (CSE: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the first quarter ended March 31, 2025. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated.

SNDL has also posted a supplemental investor presentation on its website, found at https://sndl.com.

The Company will hold a conference call and webcast presentation at 10:00 a.m. EDT (8:00 a.m. MDT) on Thursday, May 1, 2025. The conference call details can be found below.

MANAGEMENT HIGHLIGHTS

   -- Net revenue: In the first quarter of 2025, net revenue totaled $204.9 
      million, reflecting a growth rate of +3.6% compared to the same period in 
      the previous year. This increase was primarily driven by robust growth of 
      +16.8% in our combined Cannabis business. 
 
   -- Gross profit: Gross profit for the first quarter of 2025 reached $56.6 
      million, marking a strong growth of +12.4% compared to the same period in 
      the prior year. 
 
   -- Gross margin (1): The gross margin in the first quarter of 2025 was 27.6%, 
      setting a new record for the company. This represented an improvement of 
      +2.2 percentage points year-over-year. 
 
   -- Operating loss: Operating loss for the first quarter of 2025 amounted to 
      $(12.1) million. This was partially impacted by a loss of $(4.5) million 
      from the SunStream portfolio driven by a negative valuation adjustment, 
      and restructuring charges of $(3.0) million. The quarter is lapping a 
      favorable $9.1 million SunStream portfolio valuation adjustment in the 
      first quarter of 2024. 
 
   -- Cash flow: Cash flow was positive at $2.5 million during the first 
      quarter of 2025. This was driven by the collection of Delta 9's 
      outstanding loan balance of $28 million, offset in part by the repurchase 
      of SNDL's common shares and the previously announced minority investment 
      in High Tide stock. 
 
   -- Free cash flow (1): Free cash flow in the first quarter of 2025 was 
      slightly negative at $(1.1) million, despite seasonal impacts on revenue 
      and the associated build-up of working capital, representing an 
      improvement from the same quarter of 2024. 

"In the first quarter of 2025, we saw robust growth in our Cannabis segments and record aggregate Gross Margin. Our improvements in Free Cash Flow generation helped us nearly break even despite seasonal impacts and our unrestricted cash balances increased versus year end." said Zach George, Chief Executive Officer of SNDL.

"During the first quarter of 2025, we advanced several strategic initiatives to drive long-term value creation and strengthen our platform:

   -- Collected $28 million in outstanding debt from FIKA Company ("FIKA") 
      pertaining to loans previously extended to Delta 9 Cannabis Inc. ("Delta 
      9"), inclusive of an interest premium settlement 
 
   -- Received approval from the Florida Department of Health for the transfer 
      of the Parallel (Surterra Holdings, Inc.) license - an important 
      prerequisite for completing the Parallel restructuring process 
 
   -- Repurchased 5,761,735 SNDL common shares for cancellation at an average 
      price of US$1.79 per share during the first quarter of 2025 
 
   -- Completed the acquisition of 4,350,000 common shares of High Tide Inc. 
      ("High Tide"), representing 5.4% ownership 
 
   -- Announced the Company application for listing its common shares on the 
      Canadian Securities Exchange ("CSE") and commenced trading on April 11, 
      2025. 

Subsequent to the first quarter of 2025, on April 9, 2025, we announced that we had entered into an arrangement agreement to acquire 32 cannabis retail stores from 1CM Inc. ("1CM") for a total cash consideration of $32.2 million. We have also announced on April 22, 2025, the launch of our highly anticipated Rise Rewards loyalty program, designed to help Value Buds customers save more, earn more, and get even more from every visit. SNDL intends to expand the program across its retail banners in the future.

SNDL's Board of Directors has approved an amendment to the Company's share repurchase program (the "Share Repurchase Program"), as described in further detail below

Finally, our Board of Directors has initiated a formal strategic review to evaluate SNDL's exposure to U.S. multi-state licensed cannabis enterprises and its current exchange listing status, as outlined later in this document.

Our track record of operational execution, diversified asset base, and strong balance sheet - including $220.9 million of unrestricted cash as of March 31, 2025 - gives us with the flexibility to pursue both organic and inorganic opportunities with compelling returns. This review supports our long-term goal of establishing SNDL as a global cannabis leader and delivering sustainable shareholder value." concluded Zach George.

TOTAL COMPANY HIGHLIGHTS

 
                                      Three months ended March 31 
($000s)                               2025         2024      % Change 
IFRS Financial Measures 
------------------------------------ 
Net revenue                               204,914   197,750      3.6 % 
Gross profit                               56,641    50,400     12.4 % 
Operating loss                           (12,053)   (4,377)   -175.4 % 
Change in cash and cash equivalents         2,508   (6,087)      141 % 
 
Non-IFRS Financial Measures (1) 
------------------------------------ 
Gross margin                               27.6 %    25.5 %      2.2pp 
Adjusted operating loss                   (9,031)   (4,466)     -102 % 
Free cash flow                            (1,090)   (6,388)      -83 % 
 
 
 
(1)  Gross Margin is a supplementary financial measure 
      calculated by dividing Gross Profit by Net Revenue. 
      Adjusted operating income (loss) and Free Cash Flow 
      are specified financial measures that do not have 
      a standardized meanings prescribed by IFRS and therefore 
      may not be comparable to similar measures reported 
      by other companies. See "Non-IFRS Measures" section 
      below for further information. 
 

BUSINESS SEGMENT HIGHLIGHTS

SNDL operates and reports its business through four segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments. Additionally, a consolidated total for Cannabis is presented, encompassing the combined results of the two Cannabis segments, along with the revenue elimination associated with the Cannabis Operations sales to the provincial boards that are expected to be subsequently repurchased by the Company's licensed retail subsidiaries for resale. Corporate and Shared Service expenses are reported as "Corporate".

 
                                Three months ended March 31 
($000s)                         2025        2024       % Change 
Net Revenue 
------------------------------ 
Liquor Retail                      109,472    116,054     -5.7 % 
    Cannabis Retail                 77,540     71,306      8.7 % 
    Cannabis Operations             34,319     22,395     53.2 % 
    Intersegment Eliminations     (16,417)   (12,005)    -36.8 % 
                                 ---------  ---------  --------- 
Total Cannabis                      95,442     81,696     16.8 % 
Investments                             --         --        0 % 
Total                              204,914    197,750      3.6 % 
 
Operating Income 
------------------------------ 
Liquor Retail                        1,980      2,180     -9.2 % 
    Cannabis Retail                  5,162    (1,042)    595.4 % 
    Cannabis Operations              (486)        891   -154.5 % 
                                 ---------  ---------  --------- 
Total Cannabis                       4,676      (151)    >1,000% 
Investments                        (1,601)     13,079   -112.2 % 
Corporate                         (17,108)   (19,485)     12.2 % 
Total                             (12,053)    (4,377)   -175.4 % 
 
Adjusted Operating Income 
------------------------------ 
Liquor Retail                        1,980      2,180     -9.2 % 
    Cannabis Retail                  5,162    (1,042)    595.4 % 
    Cannabis Operations              2,409      1,146    110.2 % 
                                 ---------  ---------  --------- 
Total Cannabis                       7,571        104    >1,000% 
Investments                        (1,601)     13,079   -112.2 % 
Corporate                         (16,981)   (19,829)     14.4 % 
Total                              (9,031)    (4,466)   -102.2 % 
 

Liquor Retail

SNDL is Canada's largest private sector liquor retailer, operating at April 30, 2025 in 165 locations, predominantly in Alberta, under its three retail banners: "Wine and Beyond" (13), "Liquor Depot" (19), and "Ace Liquor" (133).

 
                            Three months ended March 31 
($000s)                     2025        2024       % Change 
Net revenue                    109,472    116,054     -5.7 % 
Gross profit                    27,803     28,806     -3.5 % 
Gross margin                    25.4 %     24.8 %      0.6pp 
Operating income                 1,980      2,180     -9.2 % 
Adjusted operating income        1,980      2,180     -9.2 % 
 
   -- Net revenue for Liquor Retail continued to decline in the first quarter 
      of 2025 due to ongoing market demand softness. Additionally, the first 
      quarter of 2025 had one fewer day compared to 2024, and Easter 
      consumption shifted to April 20, 2025, from March 31 in the previous 
      year. Same-store sales (2) decreased by -4.9% in the first quarter. 
 
(2)  Same store sales are specified financial measures 
      that do not have standardized meanings prescribed 
      by IFRS Accounting Standards and therefore may not 
      be comparable to similar measures used by other companies. 
      Refer to the "Non-IFRS Financial Measures and Other 
      Measures" section of this MD&A for further information. 
 
   -- Gross Margin improved to 25.4% in the first quarter of 2025, mitigating 
      the Net Revenue impact on Operating Income, as well as the lapping a $0.9 
      million impairment reversal in prior year. 

Cannabis Retail

SNDL is one of Canada's largest private-sector cannabis retailer, operating at April 30, 2025 in 186 locations under its three retail banners: "Value Buds" (121), and "Spiritleaf" (65, of which 7 are corporate stores and 58 are franchise stores). The Company's Cannabis Retail strategy is based on several pillars, including the quality of its store locations, its range of products, and the unique experiences provided to customers. Using data and insights from a large volume of monthly transactions enables SNDL to leverage technology and analytics to inform and improve its retail strategy.

 
                            Three months ended March 31 
($000s)                     2025        2024       % Change 
Net revenue                     77,540     71,306      8.7 % 
Gross profit                    19,627     18,359      6.9 % 
Gross margin                    25.3 %     25.7 %     -0.4pp 
Operating income                 5,162    (1,042)    595.4 % 
Adjusted operating income        5,162    (1,042)    595.4 % 
 
   -- Net revenue for Cannabis Retail continued to demonstrate strong growth in 
      the first quarter of 2025, driven by ongoing gains in market share. 
      Same-store sales increased by +5.2% during this period. 
 
   -- Operating Income experienced substantial growth supported by revenue 
      increases, productivity initiatives lowering SG&A, and the lapping of a 
      fixed asset impairment recorded in the prior year. 

Cannabis Operations

SNDL has a diverse brand portfolio from value to premium, emphasizing premium inhalable formats and a full suite of 2.0 products. With enhanced procurement capabilities and plans to continue evolving toward a cost-effective cultivation and manufacturing operation, the Cannabis Operations segment is a key enabler of SNDL's vertical integration strategy.

 
                            Three months ended March 31 
($000s)                     2025        2024      % Change 
Net revenue                     34,319    22,395      53.2 % 
Gross profit                     9,211     3,235     184.7 % 
Gross margin                    26.8 %    14.4 %      12.4pp 
Operating income                 (486)       891    -154.5 % 
Adjusted operating income        2,409     1,146     110.2 % 
 
   -- Cannabis Operations continues to report significant growth in both 
      revenues and profitability during the first quarter of 2025. 
 
   -- Net revenue expansion was driven by increased provincial board 
      distribution and a continued focus on consumer innovation, product 
      quality and operational efficiencies. Reported revenue for the period 
      includes $10.2 million contributed by Indiva, following its acquisition 
      in the final quarter of 2024. 
 
   -- Gross profit and Operating Income improvements are driven by efficiency 
      improvements from scale as well as productivity initiatives. 

Investments

   -- As of March 31, 2025, the Company has deployed capital to a portfolio of 
      cannabis-related investments with a carrying value of $420.3 million, 
      including $407.6 million to SunStream Bancorp Inc. ("SunStream"). This 
      carrying value was reduced by $28.8 million during the first quarter of 
      2025, mainly driven by the collection of the Delta 9 loan, and a negative 
      valuation adjustment of the SunStream portfolio. 
 
   -- In the first quarter of 2025, the investment portfolio generated negative 
      operating income of $(1.6) million, including a $(4.5) million impact 
      from our SunStream portfolio, driven by a valuation adjustment. This 
      non-cash valuation adjustment is the consequence of a reduction in the 
      bond market price of Cannabist Company Holdings Inc. ("Cannabist"). 
 
   -- In March of 2025, the Company recovered $28.0 million from FIKA, related 
      to loans previously issued to Delta 9. This amount includes $26.4 million 
      comprising the principal and outstanding interest balance 
 
   -- On February 4, 2025, the Florida Department of Health approved the 
      transfer of Parallel's license. While a few additional steps are still 
      required, this is an important milestone in completing Parallel's 
      restructuring process. 
 
   -- On March 17, 2025 the Company announced the purchase of 4,350,000 common 
      shares of High Tide, equivalent to 5.4% ownership, at an average price of 
      US$2.46 per share. 

Equity Position

   -- $641.3 million of unrestricted cash, marketable securities and 
      investments, including investments in equity-accounted investees, and no 
      outstanding debt at March 31, 2025, resulting in a net book value of $1.1 
      billion. 
 
   -- The Board of Directors has approved an amendment to the Company's Share 
      Repurchase Program announced on November 14, 2024, to increase the 
      maximum number of common shares that the Company may repurchase up to 10% 
      of the public float of the Company, subject to the approval of the CSE. 
 
   -- During the three months ending March 31, 2025, the Company repurchased 
      5,761,735 common shares for cancellation at an average price of US$1.79 
      per share. This was in addition to the 5,002,372 common shares 
      repurchased for cancelation during the fourth quarter of 2024 at an 
      average price of US$1.84 per share. 

This press release is intended to be read in conjunction with the Company's condensed consolidated interim financial statements and the notes thereto for the three months ended March 31, 2025, and the accompanying Management's Discussion and Analysis. These documents are available under the Company's profile on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov/edgar.shtml.

Strategic Review

In anticipation of the upcoming completion of the court-supervised restructurings of Parallel and Skymint, SNDL's Board of Directors has initiated a formal strategic review process to evaluate the Company's exposure to U.S. multi-state licensed cannabis enterprises and its current exchange listing status. The review aims to ensure alignment between SNDL's long-term growth strategy and its public market platform, with the overarching objective of maximizing shareholder value.

In recent months, SNDL has received inbound interest from multiple cannabis operators in both Canada and the United States that have expressed interest in being acquired or pursuing asset-level or corporate transactions. This engagement underscores SNDL's balance sheet and management strength, as well as its emerging reputation as a disciplined, retail-forward cannabis operator with international scale. As the North American cannabis industry continues to rationalize, well-capitalized consolidators like SNDL are uniquely positioned to realize synergies, drive operating leverage, and deliver sustained profitability.

To fully evaluate these opportunities and preserve strategic flexibility, the Board is assessing whether to maintain the Company's current equity market listings, or transition to an alternative structure - similar to leading U.S multi-state operators who operate outside of NYSE and Nasdaq exchange frameworks. Such a move would provide SNDL with the regulatory latitude to actively manage a broader North American cannabis platform, potentially consolidating licensed cannabis businesses across multiple U.S. states.

There is no assurance that any transaction or listing change will result from this strategic review. The Company does not intend to provide additional updates unless or until the Board has approved a specific course of action or determines that further disclosure is appropriate.

CONFERENCE CALL

The Company will hold a conference call and webcast presentation at 10:00 a.m. EDT (8:00 a.m. MDT) on Thursday, May 1, 2025.

WEBCAST ACCESS

To access the live webcast of the call, please visit the following link:

https://edge.media-server.com/mmc/p/4ikuz377

REPLAY

A replay of the webcast will be available at https://sndl.com/financials/quarterly-results/default.aspx

ABOUT SNDL INC.

SNDL Inc. (NASDAQ: SNDL, CSE: SNDL), through its wholly owned subsidiaries, is one of the largest vertically integrated cannabis companies and the largest private-sector liquor and cannabis retailer in Canada, with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds and Spiritleaf. With products available in licensed cannabis retail locations nationally, SNDL's consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Grön, No Future and Bhang Chocolate. SNDL's investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the North American cannabis industry. For more information, please visit www.sndl.com

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"), including, but not limited to, statements regarding the Company's operational goals and plans, the anticipated impact of the Company's strategic steps on long-term success and shareholder value, the anticipated impact of the Company's intentions and strategy with respect to the Rise Rewards loyalty program and retail operations, SNDL's plan to expand the program to additional retail banners, the anticipated benefit of the Company's strong balance sheet, the Company's strategy with respect to its operating segments, expectations with respect to the Parallel restructuring process, expectations with respect to the Board's strategic review process, the Company's margin improvement initiatives, the Company's ability to achieve long-term, sustainable profitability, growth and efficiencies, the Company's long-term strategic plan, the benefits of the Company's Investment Segment portfolio, the Company's retail strategy, expectations with respect to the Company's Cannabis Operations segment, , performance of the Company's investments, including through the SunStream joint venture, the timing and completion of the restructurings of with Parallel and Skymint, the timing and closing of the transaction to acquire assets from 1CM, repurchases under the Share Repurchase Program and the anticipated benefits thereof, and any other potential forms of shareholder value creation. Forward-looking statements are frequently characterized by words such as "aim", "anticipate", "assume", "believe", "contemplate", "continue", "could", "due", "estimate", "expect", "goal", "intend", "may", "objective", "plan", "predict", "potential", "positioned", "pioneer", "seek", "should", "target", "will", "would", and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the Company's business and the industry in which it operates and management's beliefs and assumptions and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond its control. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Please see "Risk Factors" in the Company's Annual Information Form dated March 18, 2025, and the risk factors included in our other public disclosure documents for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Condensed Consolidated Interim Statement of Loss and Comprehensive Loss

(Expressed in thousands of Canadian dollars, except per share amounts)

 
                                           Three months ended 
                                            March 31 
                                           2025         2024 
Net revenue                                    204,914   197,750 
Cost of sales                                  148,273   147,350 
Gross profit                                    56,641    50,400 
 
Investment income                                2,856     4,036 
Share of (loss) profit of equity-accounted 
 investees                                     (4,457)     9,148 
 
General and administrative                      46,359    44,695 
Sales and marketing                              3,767     2,598 
Research and development                           100        37 
Depreciation and amortization                   13,228    14,143 
Share-based compensation                         1,388     4,843 
Restructuring costs (recovery)                     326      (89) 
Asset impairment, net                            1,984     1,656 
(Gain) loss on disposition of assets              (59)        78 
Operating loss                                (12,053)   (4,377) 
 
Other expenses, net                            (2,654)   (3,272) 
Loss before income tax                        (14,707)   (7,649) 
Income tax recovery                                 --     2,997 
Net loss                                      (14,707)   (4,652) 
 
Equity-accounted investees - share of 
 other comprehensive 
 (loss) 
 income                                          (348)    10,034 
Investments at FVOCI - change in fair          (5,230)        -- 
value 
Comprehensive (loss) income                   (20,285)     5,382 
 
Net loss attributable to: 
Owners of the Company                         (14,707)   (2,554) 
Non-controlling interest                            --   (2,098) 
                                              (14,707)   (4,652) 
Comprehensive (loss) income 
attributable to: 
Owners of the Company                         (20,285)     7,480 
Non-controlling interest                            --   (2,098) 
                                              (20,285)     5,382 
 

Condensed Consolidated Interim Statement of Financial Position

(Expressed in thousands of Canadian dollars)

 
As at                               March 31, 2025   December 31, 2024 
 
Assets 
Current assets 
Cash and cash equivalents                   220,867            218,359 
Restricted cash                              19,792             19,815 
Marketable securities                           139                139 
Accounts receivable                          29,782             28,118 
Biological assets                             3,049              1,187 
Inventory                                   132,899            127,919 
Prepaid expenses and deposits                10,642             16,860 
Investments                                     614             27,560 
Assets held for sale                            251             19,051 
Net investment in subleases                   2,719              2,832 
                                            420,754            461,840 
Non-current assets 
Long-term deposits and receivables            3,918              3,679 
Right of use assets                         111,239            115,435 
Property, plant and equipment               158,129            145,810 
Net investment in subleases                  13,679             15,354 
Intangible assets                            60,628             61,325 
Investments                                  12,078              8,427 
Equity-accounted investees                  407,600            413,124 
Goodwill                                    124,248            124,248 
Total assets                              1,312,273          1,349,242 
 
Liabilities 
Current liabilities 
Accounts payable and accrued 
 liabilities                                 57,887             56,275 
Lease liabilities                            33,254             34,256 
Derivative warrants                              14                 26 
                                             91,155             90,557 
Non-current liabilities 
Lease liabilities                           114,692            118,017 
Other liabilities                             6,227              7,312 
Total liabilities                           212,074            215,886 
 
Shareholders' equity 
Share capital                             2,295,107          2,346,728 
Warrants                                        667                667 
Contributed surplus                          59,522             57,156 
Accumulated deficit                     (1,302,289)        (1,323,965) 
Accumulated other comprehensive 
 income                                      47,192             52,770 
Total shareholders' equity                1,100,199          1,133,356 
Total liabilities and shareholders' 
 equity                                   1,312,273          1,349,242 
 

Condensed Consolidated Interim Statement of Cash Flows

(Expressed in thousands of Canadian dollars)

 
                                           Three months ended 
                                            March 31 
                                           2025         2024 
Cash provided by (used in): 
Operating activities 
Net loss for the period                       (14,707)   (4,652) 
Adjustments for: 
Income tax recovery                                 --   (2,997) 
Interest and fee income                        (2,856)   (4,091) 
Change in fair value of biological assets      (1,111)     (232) 
Share-based compensation                         1,388     4,843 
Depreciation and amortization                   14,187    14,570 
(Gain) loss on disposition of assets              (59)        78 
Inventory impairment and obsolescence              591     1,913 
Finance costs, net                               1,690     1,625 
Change in estimate of fair value of 
 derivative warrants                              (12)     1,300 
Unrealized foreign exchange loss                    13       104 
Transaction costs                                   --       164 
Asset impairment, net                            1,984     1,656 
Share of loss (profit) of equity-accounted 
 investees                                       4,457   (9,148) 
Unrealized loss on marketable securities            --        55 
Interest received                                2,936     3,172 
Change in non-cash working capital               (713)   (5,059) 
Net cash provided by (used in) operating 
 activities                                      7,788     3,301 
Investing activities 
Additions to property, plant and equipment     (1,588)   (2,410) 
Changes to investments                          17,910       133 
Capital refunds from equity-accounted 
 investees                                          --       168 
Capital distributions from                         719        -- 
equity-accounted investees 
Proceeds from disposal of property, plant 
 and equipment                                     113      (62) 
Change in non-cash working capital                  18       495 
Net cash provided by (used in) investing 
 activities                                     17,172   (1,676) 
Financing activities 
Change in restricted cash                           --     (231) 
Payments on lease liabilities, net             (7,512)   (7,516) 
Repurchase of common shares                   (15,031)        -- 
Change in non-cash working capital                  91        35 
Net cash used in financing activities         (22,452)   (7,712) 
Change in cash and cash equivalents              2,508   (6,087) 
Cash and cash equivalents, beginning of 
 period                                        218,359   195,041 
Cash and cash equivalents, end of period       220,867   188,954 
 

NON-IFRS MEASURES

Certain specified financial measures in this news release are non-IFRS measures. These terms are not defined by IFRS and, therefore, may not be comparable to similar measures reported by other companies. These non-IFRS financial measures should not be considered in isolation or as an alternative for or superior to measures of performance prepared in accordance with IFRS. These measures are presented and described in order to provide shareholders and potential investors with additional measures in understanding the Company's operating results in the same manner as the management team.

ADJUSTED OPERATING INCOME (LOSS)

Adjusted operating income (loss) is a non-IFRS financial measure which the Company uses to evaluate its operating performance in a similar manner to its management team. The Company defines adjusted operating income (loss) as operating income (loss) less restructuring costs (recovery), goodwill and intangible asset impairments and asset impairments triggered by restructuring activities.

The following tables reconcile adjusted to un-adjusted operating income (loss) for the periods noted.

 
($000s)         Cannabis   Cannabis    Cannabis  Liquor  Investments  Corporate  Total 
                 Retail    Operations   Total    Retail 
Three months ended March 31, 2025 
Operating 
 income (loss)      5,162       (486)     4,676   1,980      (1,601)   (17,108)  (12,053) 
Adjustments: 
Restructuring 
 costs                 --         199       199      --           --        127       326 
Impairments 
 triggered by 
 restructuring         --       2,696     2,696      --           --         --     2,696 
Adjusted 
 operating 
 income 
 (loss)             5,162       2,409     7,571   1,980      (1,601)   (16,981)   (9,031) 
 
 
($000s)         Cannabis   Cannabis    Cannabis  Liquor  Investments  Corporate  Total 
                 Retail    Operations   Total    Retail 
Three months ended March 31, 2024 
Operating 
 income (loss)    (1,042)         891     (151)   2,180       13,079   (19,485)  (4,377) 
Adjustments: 
Restructuring 
 costs 
 (recovery)            --         255       255      --           --      (344)     (89) 
Adjusted 
 operating 
 income 
 (loss)           (1,042)       1,146       104   2,180       13,079   (19,829)  (4,466) 
 

GROSS MARGIN

Gross margin is a supplementary financial measure calculated by dividing gross profit by net revenue for the periods noted.

FREE CASH FLOW

Free cash flow is a non-IFRS financial measure which the Company uses to evaluate its financial performance, providing information which management believes to be useful in understanding and evaluating the Company's ability to generate positive cash flows as it removes cash used for non-operational items. The Company defines free cash flow as the total change in cash and cash equivalents less cash used for common share repurchases, dividends (if any), changes to debt instruments, changes to long-term investments, net cash used for acquisitions plus cash provided by dispositions (if any).

The following table reconciles free cash flow to change in cash and cash equivalents for the periods noted.

 
                                       Three months ended 
                                        March 31 
($000s)                                2025         2024 
Change in cash and cash equivalents          2,508   (6,087) 
Adjustments 
Repurchase of common shares                 15,031        -- 
Changes to long-term investments          (18,629)     (301) 
Free cash flow                             (1,090)   (6,388) 
 

SAME STORE SALES

Same store sales is a non-IFRS financial measure which the Company uses to evaluate its financial performance in its retail segments. Same store sales provides information which management believes to be useful to investors, analysts and others in understanding and evaluating the Company's sales trends excluding the effect of the opening and closure of stores.

Same store sales refers to the revenue generated by the Company's existing retail locations during the current and prior comparison periods.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sndl-reports-first-quarter-2025-financial-and-operational-results-302443537.html

SOURCE SNDL Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/01/c1229.html

/CONTACT:

For more information: Tomas Bottger, SNDL Inc., O: 1.587.327.2017, E: investors@sndl.com

Copyright CNW Group 2025 
 

(END) Dow Jones Newswires

May 01, 2025 07:00 ET (11:00 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10